Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lipella Pharmaceuticals Inc

2.65
+0.07002.71%
Post-market: 2.720.0700+2.64%19:55 EDT
Volume:89.04K
Turnover:236.58K
Market Cap:6.75M
PE:-0.55
High:2.74
Open:2.54
Low:2.54
Close:2.58
Loading ...
Mar 06, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 06, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 27, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 06, 2024

Correspondence

Form CORRESP - Correspondence
Jan 26, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 01, 2023

Major Issues Report

Form 8-K - Current report
Nov 29, 2023

Major Issues Report

Form 8-K - Current report
Nov 23, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2023

Correspondence

Form CORRESP - Correspondence
Nov 02, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Oct 26, 2023

Major Issues Report

Form 8-K - Current report
Sep 11, 2023

Major Issues Report

Form 8-K - Current report
Aug 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 02, 2023

Major Issues Report

Form 8-K - Current report
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
Jun 21, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 21, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]